X-51743896-T-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_018094.5(GSPT2):āc.270T>Gā(p.Asp90Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000573 in 1,203,950 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 24 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018094.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GSPT2 | NM_018094.5 | c.270T>G | p.Asp90Glu | missense_variant | 1/1 | ENST00000340438.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GSPT2 | ENST00000340438.6 | c.270T>G | p.Asp90Glu | missense_variant | 1/1 | NM_018094.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000445 AC: 5AN: 112263Hom.: 0 Cov.: 24 AF XY: 0.0000580 AC XY: 2AN XY: 34471
GnomAD3 exomes AF: 0.000115 AC: 19AN: 164723Hom.: 0 AF XY: 0.000169 AC XY: 9AN XY: 53299
GnomAD4 exome AF: 0.0000586 AC: 64AN: 1091687Hom.: 0 Cov.: 32 AF XY: 0.0000614 AC XY: 22AN XY: 358015
GnomAD4 genome AF: 0.0000445 AC: 5AN: 112263Hom.: 0 Cov.: 24 AF XY: 0.0000580 AC XY: 2AN XY: 34471
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2022 | The c.270T>G (p.D90E) alteration is located in exon 1 (coding exon 1) of the GSPT2 gene. This alteration results from a T to G substitution at nucleotide position 270, causing the aspartic acid (D) at amino acid position 90 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at